PROM1 and cancer: A recent study has demonstrated that, in contrast to the established cancer cell lines, CD133+ cells in primary colorectal cancer samples showed a unique genomic aberration profile [20], which additionally highlights the point that the use of established cancer cell line is questionable [3], [20], [78].